Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma von Jain, N, Hartert, K, Tadros, S, Fiskus, W, Havranek, O, Ma, MCJ, Bouska, A, Heavican, T, Kumar, D, Deng, Q, Moore, D, Pak, C, Liu, CL, Gentles, AJ, Hartmann, E, Kridel, R, Smedby, KE, Juliusson, G, Rosenquist, R, Gascoyne, RD, Rosenwald, A, Giancotti, F, Neelapu, SS, Westin, J, Vose, JM, Lunning, MA, Greiner, T, Rodig, S, Iqbal, J, Alizadeh, AA, Davis, RE, Bhalla, K, Green, MR

Volltext

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma von Kwak, Larry W, Neelapu, Sattva S, Kobrin, Carol B, Reynolds, Craig W, Janik, John E, Dunleavy, Kieron, White, Therese, Harvey, Linda, Pennington, Robin, Stetler-Stevenson, Maryalice, Jaffe, Elaine S, Steinberg, Seth M, Gress, Ronald, Hakim, Fran, Wilson, Wyndham H

Volltext

Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen von NEELAPU, Sattva S, BASKAR, Sivasubramanian, POPESCU, Mircea C, KWAK, Larry W, GAUSE, Barry L, KOBRIN, Carol B, WATSON, Thelma M, FRYE, Andrea Robin, PENNINGTON, Robin, HARVEY, Linda, JAFFE, Elaine S, ROBB, Richard J

Volltext

TREATMENT WITH COMBINATION OF LENALIDOMIDE AND RITUXIMAB ACHIEVES DURABLE RESPONSES IN A LONG TERM FOLLOW UP OF PATIENTS WITH INDOLENT NON‐HODGKIN'S LYMPHOMA von Chaudhry, M., Nastoupil, L., Samaniego, F., Neelapu, S.S., Hagemeister, F.B., Fanale, M.A., Fayad, L., Westin, J.R., Oki, Y., Feng, L., Fowler, N.

Volltext

HIGH RESPONSE RATES WITH PEMBROLIZUMAB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: INTERIM RESULTS OF AN ON OPEN‐LABEL, PHASE II STUDY von Nastoupil, L.J., Westin, J., Fowler, N., Fanale, M., Samaniego, F., Oki, Y., Obi, C., Cao, J., Cheng, X., Ma, M., Wang, Z., Chu, F., Feng, L., Zhou, S., Davis, R.E., Neelapu, S.S.

Volltext

Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo von Biragyn, Arya, Ruffini, Pier Adelchi, Coscia, Marta, Harvey, Linda K., Neelapu, Sattva S., Baskar, Sivasubramanian, Wang, Ji-Ming, Kwak, Larry W.

Volltext

EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT von Jamshed, S, Fowler, D H, Neelapu, S S, Dean, R M, Steinberg, S M, Odom, J, Bryant, K, Hakim, F, Bishop, M R

Volltext

PRODUCT CHARACTERISTICS ASSOCIATED WITH IN VIVO EXPANSION OF ANTI‐CD19 CAR T CELLS IN PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL (AXI‐CEL) von Neelapu, S.S., Rossi, J.M., Locke, F.L., Xue, A., Better, M., Zhang, X., Ghobadi, A., Lekakis, L.J., Miklos, D., Jacobson, C.A., Braunschweig, I., Oluwole, O., Siddiqi, T., Lin, Y., Timmerman, J., Reagan, P.M., Navale, L., Go, W.Y., Wiezorek, J., Bot, A.

Volltext

AXICABTAGENE CILOLEUCEL (AXI‐CEL; KTE‐C19) IN PATIENTS WITH REFRACTORY AGGRESSIVE NON‐HODGKIN LYMPHOMAS (NHL): PRIMARY RESULTS OF THE PIVOTAL TRIAL ZUMA‐1 von Neelapu, S.S., Locke, F.L., Bartlett, N.L., Lekakis, L.J., Miklos, D., Jacobson, C.A., Braunschweig, I., Oluwole, O., Siddiqi, T., Lin, Y., Timmerman, J., Reagan, P., Navale, L., Jiang, Y., Aycock, J., Elias, M., Wiezorek, J., Go, W.Y.

Volltext

Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines von Ruffini, PA, Neelapu, SS, Kwak, LW, Biragyn, A

Volltext

Induction of TLR4-dependent CD8+ T cell immunity by murine [beta]-defensin2 fusion protein vaccines von Park, HJ, Qin, H, Cha, SC, Sharma, R, Chung, Y, Schluns, KS, Neelapu, SS, Overwijk, WW, Hwu, P, Kwak, LW

Volltext

Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion von Kwak, Larry W, Neelapu, Sattva S, Bishop, Michael R

Volltext

Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy von Morris, EC, Neelapu, SS, Giavridis, T, Sadelain, M

Volltext bestellen

Detection of keyhole limpet hemocyanin (KLH)-specific immune responses by intracellular cytokine assay in patients vaccinated with idiotype-KLH vaccine von NEELAPU, Sattva S, BASKAR, Sivasubramanian, KWAK, Larry W

Volltext

ASBMT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells von Lee, DW, Santomasso, BD, Locke, FL, Ghobadi, A, Turtle, CJ, Brudno, JN, Maus, MV, Park, JH, Mead, E, Pavletic, S, Go, WY, Eldjerou, L, Gardner, RA, Frey, N, Curran, KJ, Peggs, K, Pasquini, M, DiPersio, JF, van den Brink, MRM, Komanduri, KV, Grupp, SA, Neelapu, SS

Volltext bestellen